Cyberonics to Present at Maxim Group Growth Conference
17 September 2009 - 11:00PM
PR Newswire (US)
HOUSTON, Sept. 17 /PRNewswire-FirstCall/ -- Cyberonics, Inc.
(NASDAQ: CYBX) today announced that James Reinstein, Cyberonics'
Vice President, Sales & Marketing and General Manager,
International, will present at the Maxim Group Growth Conference in
New York on Tuesday, September 29, 2009 at 2:30 PM EDT. Maxim will
host a webcast of the presentation live and by replay at
http://www.wsw.com/webcast/maxim2/cybx/. The replay will be
available for 90 days following the conference. Presentation slides
will be available on-line at http://www.cyberonics.com/ by 8:00 AM
EDT on Tuesday, September 29, 2009. The presentation can also be
accessed at http://www.cyberonics.com/ by clicking on the link for
this webcast. Access to the webcast is not password protected.
About Cyberonics, Inc. and VNS Therapy(TM) Cyberonics, Inc.
(NASDAQ:CYBX) is a medical technology company with core expertise
in neuromodulation. The company developed and markets the Vagus
Nerve Stimulation (VNS) Therapy(TM) System, which is FDA-approved
for the treatments of refractory epilepsy and treatment-resistant
depression. The VNS Therapy System uses a surgically implanted
medical device that delivers pulsed electrical signals to the vagus
nerve. Cyberonics markets the VNS Therapy System in selected
markets worldwide. Additional information on Cyberonics, Inc. and
VNS Therapy(TM) is available at http://www.cyberonics.com/ and
http://www.vnstherapy.com/. CONTACT INFORMATION: Greg Browne, CFO
Cyberonics, Inc. 100 Cyberonics Blvd. Houston, TX 77058 Main: (281)
228-7262 Fax: (281) 218-9332 DATASOURCE: Cyberonics, Inc. CONTACT:
Greg Browne, CFO of Cyberonics, Inc., +1-281-228-7262, fax,
+1-281-218-9332, Web Site: http://www.cyberonics.com/
http://www.wsw.com/webcast/maxim2/cybx http://www.vnstherapy.com/
Copyright